These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15469389)

  • 1. Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.
    Cook AD; Visvanathan K
    Expert Opin Ther Targets; 2004 Oct; 8(5):375-90. PubMed ID: 15469389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological roles for IL-18 in inflammatory arthritis.
    Matsui K; Tsutsui H; Nakanishi K
    Expert Opin Ther Targets; 2003 Dec; 7(6):701-24. PubMed ID: 14640907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current conception of rheumatoid polyarthritis treatment: towards a therapeutic revolution?].
    Sany J
    Bull Acad Natl Med; 2003; 187(5):957-73; discussion 973-6. PubMed ID: 14979059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches to the therapy of autoimmune diseases: rheumatoid arthritis as a paradigm.
    Moreland LW; Heck LW; Sullivan W; Pratt PW; Koopman WJ
    Am J Med Sci; 1993 Jan; 305(1):40-51. PubMed ID: 8416681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological therapy in rheumatoid arthritis].
    Abraham Simón J
    Rev Invest Clin; 2001; 53(5):452-9. PubMed ID: 11795111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases.
    Pers YM; Jorgensen C
    Immunotherapy; 2016 Sep; 8(9):1091-6. PubMed ID: 27485081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospects of the anti-cytokine therapy in rheumatoid arthritis].
    Lukina GV
    Vestn Ross Akad Med Nauk; 2003; (7):23-7. PubMed ID: 12934466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic therapies in clinical development for the treatment of rheumatoid arthritis.
    Genovese MC
    J Clin Rheumatol; 2005 Jun; 11(3 Suppl):S45-54. PubMed ID: 16357750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the T cell in autoimmune inflammation.
    Skapenko A; Leipe J; Lipsky PE; Schulze-Koops H
    Arthritis Res Ther; 2005; 7 Suppl 2(Suppl 2):S4-14. PubMed ID: 15833146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emerging therapy in rheumatoid arthritis].
    Kańska U; Boratyński J
    Postepy Hig Med Dosw (Online); 2008 Feb; 62():94-102. PubMed ID: 18334924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapies for rheumatoid arthritis.
    Tremoulet AH; Albani S
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1427-41. PubMed ID: 17040201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptides.
    Mouzaki A; Deraos S; Chatzantoni K
    Curr Med Chem; 2005; 12(13):1537-50. PubMed ID: 15974986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological therapies: a novel approach to the treatment of autoimmune disease.
    Fox DA
    Am J Med; 1995 Jul; 99(1):82-8. PubMed ID: 7598148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New ways in the management of rheumatoid arthritis in Hungary].
    Gergely P; Poór G
    Lege Artis Med; 2007 Oct; 17(10):657-64. PubMed ID: 19227595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study.
    Ferraro-Peyret C; Coury F; Tebib JG; Bienvenu J; Fabien N
    Arthritis Res Ther; 2004; 6(6):R535-43. PubMed ID: 15535831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects.
    Dalakas MC
    Ann Neurol; 1995 May; 37 Suppl 1():S2-13. PubMed ID: 8968213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.
    Xu WD; Zhang M; Zhang YJ; Ye DQ
    Hum Immunol; 2013 Sep; 74(9):1057-60. PubMed ID: 23800433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
    Alam J; Jantan I; Bukhari SNA
    Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.